398 results on '"Benkelfat, C."'
Search Results
102. Neuroendocrine and hypothermic effects of intravenous injection of the selective 5-HT~1~A receptor agonist flesinoxan in humans
- Author
-
Benkelfat, C., Blier, P., Seletti, B., and Gilbert, F.
- Published
- 1993
- Full Text
- View/download PDF
103. Serotonin and Alcohol Intake, Abuse and Dependence: Findings of Animal Studies
- Author
-
LeMarquand, D., Pihl, R. O., and Benkelfat, C.
- Published
- 1994
- Full Text
- View/download PDF
104. Serotin and Alcohol Intake, Abuse, and Dependence: Clinical Evidence
- Author
-
LeMarquand, D., Pihl, R. O., and Benkelfat, C.
- Published
- 1994
- Full Text
- View/download PDF
105. Serum Antibody for Somatostatin-14 and Prodynorphin 209-240 in Patients with Obsessive-Compulsive Disorder, Schizophrenia, Alzheimer's Disease, Multiple Sclerosis, and Advanced HIV Infection
- Author
-
Roy, B. F., Benkelfat, C., Hill, J. L., and Pierce, P. F.
- Published
- 1994
- Full Text
- View/download PDF
106. Elevated caudate DOPA decarboxylase activity in vivo in schizophrenia and temporal lobe epilepsy with psychosis
- Author
-
Reith, J, Benkelfat, C, Kuwabara, H, Savard, G, Chouinard, G, Andermann, F, Sherwin, A, Dyve, Suzan, Cumming, P, Lal, S, Etienne, P, Bachneff, S, and Gjedde, A
- Published
- 1991
- Full Text
- View/download PDF
107. Limbic system mGluR5 availability in cocaine dependent subjects: A high-resolution PET [11C]ABP688 study.
- Author
-
Milella, M. S., Marengo, L., Larcher, K., Fotros, A., Dagher, A., Rosa-Neto, P., Benkelfat, C., and Leyton, M.
- Subjects
- *
COCAINE , *POSITRON emission tomography , *BIOAVAILABILITY , *DRUG administration , *GLUTAMATE receptors , *LABORATORY rats - Abstract
Cocaine self-administration decreases type 5 metabotropic glutamate receptor (mGluR5) tissue concentrations in laboratory rats during early abstinence. These changes are thought to influence the drug's reinforcing properties and the ability of drug-related cues to induce relapse. Here, our goal was to measure brain regional mGluR5 availability in recently abstinent cocaine dependent humans. Participants meeting DSM-IV diagnostic criteria for current cocaine dependence (n=9) were recruited from the general population. mGluR5 availability (binding potential, non-displaceable; BPND) was measured with high-resolution positron emission tomography (PET HRRT) and [11C]ABP688. Compared to age- and sex-matched healthy controls (n=9), cocaine dependent subjects showed significantly lower BPND values in the ventral (bilateral: -28.2%, p=0.011), associative (right: -21.4%, p=0.043), and sensorimotor striatum (bilateral: -21.7%, p=0.045), amygdala (left: -26%, p=0.046) and insula (right: -23.3%, p=0.041). Among the cocaine users, receptor availabilities were related to abstinence (range: 2 to 14days). The longer the duration of abstinence, the lower the BPND values in the sensorimotor striatum (r=-0.71, p=0.034), left amygdala (r=-0.73, p=0.026) and right insula (r=-0.67, p=0.046). Compared to healthy controls, BPND values were significantly reduced in those who tested negative for cocaine on the PET test session in the ventral (p=0.018) and sensorimotor striatum (p=0.017), left amygdala (p=0.008), and right insula (p=0.029), but not in those who tested positive. Together, these results provide evidence of time-related mGluR5 alterations in striatal and limbic regions in humans during early cocaine abstinence. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
108. Acute prefrontal cortex TMS in healthy volunteers: Effects on brain 11C-αMtrp trapping
- Author
-
Sibon, I., Strafella, A.P., Gravel, P., Ko, J.H., Booij, L., Soucy, J.P., Leyton, M., Diksic, M., and Benkelfat, C.
- Subjects
- *
PREFRONTAL cortex , *TRANSCRANIAL magnetic stimulation , *OCCIPITAL lobe , *VOLUNTEERS - Abstract
Abstract: High-frequency repetitive transcranial magnetic stimulation (rTMS) of the left dorsolateral prefrontal cortex (LDLPFC) is a technique with purported efficacy as a treatment for major depression. Here, we assessed in vivo, in healthy volunteers, the effect of acute rTMS of the LDLPFC, relative to the stimulation of the left occipital cortex (LOC), on brain regional serotonin synthesis capacity, using the [11C]-alpha-methyl-tryptophan (11C-αMtrp)/PET method. Ten subjects were studied twice, once following rTMS of the LDLPFC and once following rTMS of the LOC in a randomized counterbalanced order. Three blocks of 15 trains of 10 Hz rTMS were delivered 10 min apart. Behavioural and autonomic measures were recorded before and after each rTMS session. Comparisons of TMS-related changes in regional normalized brain uptake and trapping of 11C-αMtrp (K*) values were carried out using SPM99. Statistically significant regional differences were identified on the basis of an extent threshold of 50 voxels, with a peak threshold of p =0.005 uncorrected. Behavioural and autonomic measures were unaffected by rTMS. Relative to LOC stimulation, LDLPFC rTMS was associated with marked changes in normalized K* in limbic areas, with significantly lower values in the left parahippocampal gyrus (BA 28) and the right insula (BA 13), and higher values in the right cingulate gyrus (BA 31) and cuneus (BA 18). These findings indicate that acute rTMS of the LDLPFC in healthy volunteers modulates aspects of tryptophan/5-HT metabolism in limbic areas. Such adaptive changes may contribute to the mechanism of action of prefrontal rTMS in major depression. [Copyright &y& Elsevier]
- Published
- 2007
- Full Text
- View/download PDF
109. Cortical trapping of α-[11C]methyl-l-tryptophan, an index of serotonin synthesis, is lower in females than males
- Author
-
Sakai, Y., Nishikawa, M., Leyton, M., Benkelfat, C., Young, S.N., and Diksic, M.
- Subjects
- *
SEROTONIN , *AMINO acids , *CEREBRAL cortex ,SEX differences (Biology) - Abstract
Abstract: One neural system that may exhibit gender differences is serotonin (5-HT), a neurotransmitter implicated in the regulation of mood, cognitive processes, and impulse-control. However, most of the available evidence of gender-related differences in this system has been indirect and at times contradictory. The objective of the present study was to follow up on preliminary evidence that there are gender differences in brain regional 5-HT synthesis, as measured by trapping of α-[11C]methyl-l-tryptophan (α-[11C]MTrp). Sixty-minute dynamic scans were performed in healthy volunteers, 28 women and 31 men. Functional images of the brain trapping constant, used as a proxy for 5-HT synthesis, which correlate in the rat brain with tryptophan''s conversion into 5-HT, were transferred to the standardized 3D space. The voxel based comparison was performed by Statistical Parametric Mapping with proportional normalization. There was lower normalized α-[11C]MTrp trapping in females than males throughout much of the cerebral cortex, including the left middle frontal gyrus, the bilateral inferior frontal gyrus, the bilateral precentral gyrus, the left supramarginal gyrus, the bilateral inferior parietal lobule, the left superior temporal gyrus, the bilateral posterior cingulate gyrus, and the bilateral precuneus. There were no regions in which the normalized trapping was significantly higher in females than in males. Gender differences in sub-cortical sites were not found. Women, compared to men, may have lower rates of this tracer trapping, used as a proxy for 5-HT synthesis, throughout much of the cerebral cortex which is likely related to differences in 5-HT synthesis because relative differences in the normalized trapping should be the same as those in 5-HT synthesis. These differences may be related, at least in part, to previously suggested gender differences in affect, cognitive processes, and susceptibility to 5-HT-related neuropsychiatric and neurological disorders. [Copyright &y& Elsevier]
- Published
- 2006
- Full Text
- View/download PDF
110. Increasing blood oxygen increases an index of 5-HT synthesis in human brain as measured using α-[11C]methyl-l-tryptophan and positron emission tomography
- Author
-
Nishikawa, M., Kumakura, Y., Young, S.N., Fiset, P., Vogelzangs, N., Leyton, M., Benkelfat, C., and Diksic, M.
- Subjects
- *
POSITRON emission tomography , *AMINO acids , *MEDICAL imaging systems , *COMPUTER-aided diagnosis - Abstract
Abstract: The main objective of this investigation was to test the hypothesis that brain serotonin (5-HT) synthesis, as measured by trapping of α-[11C]methyl-l-tryptophan (α-MTrp) using positron emission tomography (PET), can be modulated by changes in blood oxygen. The study involved six healthy participants (three male and three female), who breathed a 15% or 60% oxygen mixture starting 15 min before the injection of tracer and continuing during the entire acquisition period. Participants were injected with up to 12mCi of α-MTrp. Two sets of PET images were acquired while the participants were breathing each of the oxygen mixtures and, after reconstruction, all images were converted into brain functional images illustrating the brain trapping constant K * (μL/g/min). The K * values were obtained for 12 regions of interest outlined on the magnetic resonance images. The K * values obtained at high and low blood oxygen content were compared by paired statistics using Tukey''s post hoc correction. As there were no difference in plasma tryptophan concentrations, these K * values are directly related to regional 5-HT synthesis. The results showed highly significant increases (50% on average) in brain serotonin synthesis (K * values) at high (mean value of 223±41mmHg) relative to low (mean value 77.1±7.7mmHg) blood oxygen levels. This suggests that tryptophan hydroxylase is not saturated with oxygen in the living human brain and that increases in blood oxygen can elevate brain serotonin synthesis. [Copyright &y& Elsevier]
- Published
- 2005
- Full Text
- View/download PDF
111. 497 - Brain dopa-decarboxylase (DDC) activity in unmedicated schizophrenic patients
- Author
-
Benkelfat, C., Nishizawa, S., Kuwabara, H., Lal, S., Chouinard, G., Cumming, P., Labelle, A., Joober, R., Bruce, K., Dikksic, M., and Gjedde, A.
- Published
- 1997
- Full Text
- View/download PDF
112. 39-50 - CAG repeat containing genes and schizophrenia: An association study
- Author
-
Joober, R., Benkelfat, C., Lafrontière, R., Lal, S., Lalonde, P., Labelle, A., Turecki, G., Palmour, R., O’Driscoll, G., and Rouleau, G.A.
- Published
- 1997
- Full Text
- View/download PDF
113. 39-49 - Polyglutamin containing proteins in schizophrenia
- Author
-
Joober, R., Benkelfat, C., Mandel, J.L., Lopes-Cendes, I., Lal, S., Lalonde, P., Labelle, A., Palmour, R., O’Driscoll, G., and Rouleau, G.A.
- Published
- 1997
- Full Text
- View/download PDF
114. 10-7 - Brain regional rates of serotonin synthesis in patients with borderline personality disorder: A PET study with α-[ 11C]methyl-L-tryptophan
- Author
-
Leyton, M., Diksic, M., Young, S.N., Okazawa, H., Nishizawa, S., Paris, J., Mzengeza, S., and Benkelfat, C.
- Published
- 1997
- Full Text
- View/download PDF
115. Neuroendocrine and hypothermic effects of intravenous injection of the selective 5-HT 1A receptor agonist flesinoxan in humans
- Author
-
Benkelfat, C., Blier, P., Seletti, B., Gilbert, F., and de Montigny, C.
- Published
- 1993
- Full Text
- View/download PDF
116. Drug-associated context increases dopamine release during placebo administration: A PET [11C]raclopride study in healthy volunteers
- Author
-
Boileau, Isabelle, Dagher, A., Welfeld, K., Leyton, M., Booij, L., Sibon, I., Diksic, M., and Benkelfat, C.
- Published
- 2006
- Full Text
- View/download PDF
117. Radiosynthesis and In Vivo Evaluation of Four Positron Emission Tomography Tracer Candidates for Imaging of Melatonin Receptors.
- Author
-
Bdair H, Singleton TA, Ross K, Jolly D, Kang MS, Aliaga A, Tuznik M, Kaur T, Yous S, Soucy JP, Massarweh G, Scott PJH, Koeppe R, Spadoni G, Bedini A, Rudko DA, Gobbi G, Benkelfat C, Rosa-Neto P, Brooks AF, and Kostikov A
- Subjects
- Animals, Brain diagnostic imaging, Brain metabolism, Fluorine Radioisotopes metabolism, Ligands, Mammals metabolism, Positron-Emission Tomography methods, Radiopharmaceuticals, Rats, Receptors, Melatonin metabolism, Melatonin metabolism
- Abstract
Melatonin is a neurohormone that modulates several physiological functions in mammals through the activation of melatonin receptor type 1 and 2 (MT
1 and MT2 ). The melatonergic system is an emerging therapeutic target for new pharmacological interventions in the treatment of sleep and mood disorders; thus, imaging tools to further investigate its role in the brain are highly sought-after. We aimed to develop selective radiotracers for in vivo imaging of both MT1 and MT2 by positron emission tomography (PET). We identified four previously reported MT ligands with picomolar affinities to the target based on different scaffolds which were also amenable for radiolabeling with either carbon-11 or fluorine-18. [11 C]UCM765, [11 C]UCM1014, [18 F]3-fluoroagomelatine ([18 F]3FAGM), and [18 F]fluoroacetamidoagomelatine ([18 F]FAAGM) have been synthesized in high radiochemical purity and evaluated in wild-type rats. All four tracers showed moderate to high brain permeability in rats with maximum standardized uptake values (SUVmax of 2.53, 1.75, 3.25, and 4.47, respectively) achieved 1-2 min after tracer administration, followed by a rapid washout from the brain. Several melatonin ligands failed to block the binding of any of the PET tracer candidates, while in some cases, homologous blocking surprisingly resulted in increased brain retention. Two18 F-labeled agomelatine derivatives were brought forward to PET scans in non-human primates and autoradiography on human brain tissues. No specific binding has been detected in blocking studies. To further investigate pharmacokinetic properties of the putative tracers, microsomal stability, plasma protein binding, log D , and membrane bidirectional permeability assays have been conducted. Based on the results, we conclude that the fast first pass metabolism by the enzymes in liver microsomes is the likely reason of the failure of our PET tracer candidates. Nevertheless, we showed that PET imaging can serve as a valuable tool to investigate the brain permeability of new therapeutic compounds targeting the melatonergic system.- Published
- 2022
- Full Text
- View/download PDF
118. Externalizing Risk Pathways for Adolescent Substance Use and Its Developmental Onset: A Canadian Birth Cohort Study: Trajectoires de comportements extériorisés et le risque pour l'initiation et l'usage de substances des adolescents : Une étude de cohorte de naissance canadienne.
- Author
-
Cox SML, Castellanos-Ryan N, Parent S, Benkelfat C, Vitaro F, Pihl RO, Boivin M, Tremblay RE, Leyton M, and Séguin JR
- Subjects
- Adolescent, Canada epidemiology, Child, Child, Preschool, Cohort Studies, Female, Humans, Infant, Pregnancy, Prospective Studies, Birth Cohort, Substance-Related Disorders epidemiology
- Abstract
Objective: Only a minority of drug and alcohol users develops a substance use disorder. Previous studies suggest that this differential vulnerability commonly reflects a developmental trajectory characterized by diverse externalizing behaviors. In this study, we examined the relation between child and adolescent externalizing behaviors and adolescent substance use in a prospectively followed Canadian birth cohort, accounting for the temporal sequence of a wide variety of contributing factors., Methods: Two hundred and forty-two adolescents followed since birth (date range: 1996 to 2012) were assessed on externalizing behavior (age 17 months to 16 years), alcohol and cannabis use at age 16, age of alcohol use onset, family history of substance use problems, family functioning (age 11 to 15), sensation seeking (age 16), prenatal substance exposure, socioeconomic status (age 1 to 9), and sex., Results: Age of alcohol use onset was predicted by a family history of substance use problems, externalizing traits from ages 6 to 10 and 11 to 16, sensation seeking at age 16, prenatal alcohol and tobacco exposure and family functioning at ages 11 to 15. High frequencies of alcohol and cannabis use at age 16 were both predicted by externalizing traits from ages 11 to 16, a family history of substance use problems and sensation seeking after controlling for other individual, environmental and familial variables. The association between familial substance use problems and substance use during adolescence was partially mediated by externalizing traits from age 11 to 16., Conclusions: The present findings provide prospective evidence for a developmental risk pathway for adolescent substance use, potentially identifying those who could benefit from early interventions.
- Published
- 2021
- Full Text
- View/download PDF
119. Metabotropic glutamate type 5 receptor binding availability during dextroamphetamine sensitization in mice and humans.
- Author
-
Smart K, Nagano-Saito A, Milella MS, Sakae DY, Favier M, Vigneault E, Louie L, Hamilton A, Ferguson SSG, Rosa-Neto P, Narayanan S, El Mestikawy S, Leyton M, and Benkelfat C
- Subjects
- Adult, Animals, Behavior, Animal drug effects, Central Nervous System Stimulants administration & dosage, Dextroamphetamine administration & dosage, Female, Fluorescent Antibody Technique, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Mice, Transgenic, Oximes pharmacokinetics, Positron-Emission Tomography, Pyridines pharmacokinetics, Receptor, Metabotropic Glutamate 5 antagonists & inhibitors, Central Nervous System Sensitization drug effects, Central Nervous System Stimulants pharmacology, Corpus Striatum diagnostic imaging, Corpus Striatum drug effects, Corpus Striatum metabolism, Dextroamphetamine pharmacology, Locomotion drug effects, Prefrontal Cortex diagnostic imaging, Prefrontal Cortex drug effects, Prefrontal Cortex metabolism, Psychomotor Performance drug effects, Receptor, Metabotropic Glutamate 5 drug effects, Receptor, Metabotropic Glutamate 5 metabolism
- Abstract
Background: Glutamate transmission is implicated in drug-induced behavioural sensitization and the associated long-lasting increases in mesolimbic output. Metabotropic glutamate type 5 (mGlu5) receptors might be particularly important, but most details are poorly understood., Methods: We first assessed in mice (n = 51, all male) the effects of repeated dextroamphetamine administration (2.0 mg/kg, i.p.) on locomotor activity and binding of the mGlu5 ligand [3H]ABP688. In a parallel study, in 19 stimulant-drug-naïve healthy human volunteers (14 female) we administered 3 doses of dextroamphetamine (0.3 mg/kg, p.o.) or placebo, followed by a fourth dose 2 weeks later. We measured [11C]ABP688 binding using positron emission tomography before and after the induction phase. We assessed psychomotor and behavioural sensitization using speech rate, eye blink rate and self-report. We measured the localization of mGlu5 relative to synaptic markers in mouse striatum using immunofluorescence., Results: We observed amphetamine-induced psychomotor sensitization in mice and humans. We did not see group differences in mGlu5 availability following 3 pre-challenge amphetamine doses, but group differences did develop in mice administered 5 doses. In mice and humans, individual differences in mGlu5 binding after repeated amphetamine administration were negatively correlated with the extent of behavioural sensitization. In drug-naïve mice, mGlu5 was expressed at 67% of excitatory synapses on dendrites of striatal medium spiny neur., Limitations: Correlational results should be interpreted as suggestive because of the limited sample size. We did not assess sex differences., Conclusion: Together, these results suggest that changes in mGlu5 availability are not part of the earliest neural adaptations in stimulant-induced behavioural sensitization, but low mGlu5 binding might identify a higher propensity for sensitization., Competing Interests: M. Leyton is an associate editor of JPN. He was not involved in reviewing or the decision to accept this paper for publication., (© 2021 Joule Inc. or its licensors.)
- Published
- 2021
- Full Text
- View/download PDF
120. mGlu5 receptor availability in youth at risk for addictions: effects of vulnerability traits and cannabis use.
- Author
-
Cox SML, Tippler M, Jaworska N, Smart K, Castellanos-Ryan N, Durand F, Allard D, Benkelfat C, Parent S, Dagher A, Vitaro F, Boivin M, Pihl RO, Côté S, Tremblay RE, Séguin JR, and Leyton M
- Subjects
- Adolescent, Adult, Brain diagnostic imaging, Brain metabolism, Carbon Radioisotopes, Humans, Longitudinal Studies, Positron-Emission Tomography, Receptor, Metabotropic Glutamate 5 metabolism, Young Adult, Cannabis metabolism
- Abstract
The excitatory neurotransmitter glutamate has been implicated in experience-dependent neuroplasticity and drug-seeking behaviors. Type 5 metabotropic glutamate (mGlu5) receptors might be particularly important. They are critically involved in synaptic plasticity and their availability has been reported to be lower in people with alcohol, tobacco, and cocaine use disorders. Since these reductions could reflect effects of drug use or pre-existing traits, we used positron emission tomography to measure mGlu5 receptor availability in young adults at elevated risk for addictions. Fifty-nine participants (age 18.5 ± 0.6) were recruited from a longitudinal study that has followed them since birth. Based on externalizing traits that predict future substance use problems, half were at low risk, half were at high risk. Cannabis use histories varied markedly and participants were divided into three subgroups: zero, low, and high use. Compared to low risk volunteers, those at elevated risk had lower [
11 C]ABP688 binding potential (BPND ) values in the striatum, amygdala, insula, and orbitofrontal cortex (OFC). Cannabis use by risk group interactions were observed in the striatum and OFC. In these regions, low [11 C]ABP688 BPND values were only seen in the high risk group that used high quantities of cannabis. When these high risk, high cannabis use individuals were compared to all other participants, [11 C]ABP688 BPND values were lower in the striatum, OFC, and insula. Together, these results provide evidence that mGlu5 receptor availability is low in youth at elevated risk for addictions, particularly those who frequently use cannabis.- Published
- 2020
- Full Text
- View/download PDF
121. Extra-striatal D 2/3 receptor availability in youth at risk for addiction.
- Author
-
Jaworska N, Cox SML, Tippler M, Castellanos-Ryan N, Benkelfat C, Parent S, Dagher A, Vitaro F, Boivin M, Pihl RO, Côté SM, Tremblay RE, Séguin JR, and Leyton M
- Subjects
- Adolescent, Humans, Impulsive Behavior, Positron-Emission Tomography, Receptors, Dopamine D3 metabolism, Corpus Striatum diagnostic imaging, Corpus Striatum metabolism, Receptors, Dopamine D2 metabolism
- Abstract
The neurobiological traits that confer risk for addictions remain poorly understood. However, dopaminergic function throughout the prefrontal cortex, limbic system, and upper brainstem has been implicated in behavioral features that influence addiction vulnerability, including poor impulse control, and altered sensitivity to rewards and punishments (i.e., externalizing features). To test these associations in humans, we measured type-2/3 dopamine receptor (DA
2/3 R) availability in youth at high vs. low risk for substance use disorders (SUDs). In this study, N = 58 youth (18.5 ± 0.6 years) were recruited from cohorts that have been followed since birth. Participants with either high (high EXT; N = 27; 16 F/11 M) or low pre-existing externalizing traits (low EXT; N = 31; 20 F/11 M) underwent a 90-min positron emission tomography [18 F]fallypride scan, and completed the Barratt Impulsiveness Scale (BIS-11), Substance Use Risk Profile scale (SURPS), and Sensitivity to Punishment (SP) and Sensitivity to Reward (SR) questionnaire. We found that high vs. low EXT trait participants reported elevated substance use, BIS-11, SR, and SURPS impulsivity scores, had a greater prevalence of psychiatric disorders, and exhibited higher [18 F]fallypride binding potential (BPND ) values in prefrontal, limbic and paralimbic regions, even when controlling for substance use. Group differences were not evident in midbrain dopamine cell body regions, but, across all participants, low midbrain BPND values were associated with low SP scores. Together, the results suggest that altered DA2/3 R availability in terminal extra-striatal and dopamine cell body regions might constitute biological vulnerability traits, generating an EXT trajectory for addictions with and without co-occurring alterations in punishment sensitivity (i.e., an internalizing feature).- Published
- 2020
- Full Text
- View/download PDF
122. Dopaminergic Plasticity in the Bilateral Hippocampus Following Threat Reversal in Humans.
- Author
-
Lissemore JI, Nagano-Saito A, Smart K, Gravel P, Leyton M, and Benkelfat C
- Subjects
- Adult, Conditioning, Psychological, Cues, Female, Healthy Volunteers, Hippocampus diagnostic imaging, Hippocampus physiology, Humans, Male, Positron-Emission Tomography, Dopamine metabolism, Hippocampus metabolism, Neuronal Plasticity
- Abstract
When a cue no longer predicts a threat, a diminished ability to extinguish or reverse this association is thought to increase risk for stress-related disorders. Despite the clear clinical relevance, the mediating neurochemical mechanisms of threat reversal have received relatively little study. One neurotransmitter implicated in rodent research of changing associations with threat is dopamine. To study whether dopamine is involved in threat reversal in humans, we used high-resolution positron emission tomography (PET) coupled with
18 F-fallypride. Twelve healthy volunteers (6 F/6 M) underwent three PET scans: (i) at baseline, (ii) following threat conditioning (the response to a cue associated with electric wrist shock), and (iii) following threat reversal (the response to the same cue now associated with safety). We observed moderate evidence of reduced dopamine D2/3 receptor availability, consistent with greater dopamine release, in the bilateral anterior hippocampus following threat reversal, in response to a safety cue that was previously associated with threat, as compared to both baseline and during exposure to the same cue prior to threat reversal. These findings offer the first preliminary evidence that the response to a previously threatening cue that has since become associated with safety involves dopaminergic neurotransmission within the hippocampus in healthy humans.- Published
- 2020
- Full Text
- View/download PDF
123. Radiosynthesis of the diastereomerically pure (E)-[ 11 C]ABP688.
- Author
-
Bdair H, Tsai IH, Smart K, Benkelfat C, Leyton M, and Kostikov A
- Subjects
- Chemistry Techniques, Synthetic, Positron-Emission Tomography, Radiochemistry, Stereoisomerism, Carbon Radioisotopes chemistry, Oximes chemical synthesis, Oximes chemistry, Pyridines chemical synthesis, Pyridines chemistry
- Abstract
We report an efficient protocol for the radiosynthesis of diastereomerically pure (E)-[
11 C]ABP688, a positron emission tomography (PET) tracer for metabotropic glutamate type 5 (mGlu5) receptor imaging. The protocol reliably provides sterile and pyrogen-free formulation of (E)-[11 C]ABP688 suitable for preclinical and clinical PET imaging with >99% diastereomeric excess (d.e.), >99% overall radiochemical purity (RCP), 14.9 ± 4.3% decay-corrected radiochemical yield (RCY), and 148.86 ± 79.8 GBq/μmol molar activity in 40 minutes from the end of bombardment., (© 2019 John Wiley & Sons, Ltd.)- Published
- 2019
- Full Text
- View/download PDF
124. Sex differences in [ 11 C]ABP688 binding: a positron emission tomography study of mGlu5 receptors.
- Author
-
Smart K, Cox SML, Scala SG, Tippler M, Jaworska N, Boivin M, Séguin JR, Benkelfat C, and Leyton M
- Subjects
- Brain diagnostic imaging, Brain metabolism, Female, Healthy Volunteers, Humans, Male, Protein Binding, Young Adult, Carbon Radioisotopes, Oximes metabolism, Positron-Emission Tomography, Pyridines metabolism, Receptor, Metabotropic Glutamate 5 metabolism, Sex Characteristics
- Abstract
Purpose: The purpose of this study was to assess, in a large sample of healthy young adults, sex differences in the binding potential of [
11 C]ABP688, a positron emission tomography (PET) tracer selective for the metabotropic glutamate type 5 (mGlu5) receptor., Methods: High resolution [11 C]ABP688 PET scans were acquired in 74 healthy volunteers (25 male, 49 female, mean age 20 ± 3.0). Mean binding potential (BPND = fND * (Bavail / KD )) values were calculated in the prefrontal cortex, striatum, and limbic regions using the simplified reference tissue model with cerebellar grey matter as the reference region., Results: [11 C]ABP688 BPND was significantly higher in men compared to women in the prefrontal cortex (p < 0.01), striatum (p < 0.001), and hippocampus (p < 0.05). Whole-brain BPND was 17% higher in men. BPND was not related to menstrual phase in women., Conclusions: Binding availability of mGlu5 receptors as measured by PET [11 C]ABP688 is higher in healthy men than women. This likely represents a source of variability in [11 C]ABP688 studies and could have relevance for sex differences in cognitive-behavioral functions and neuropsychiatric disorders.- Published
- 2019
- Full Text
- View/download PDF
125. Effect of (Z)-isomer content on [ 11 C]ABP688 binding potential in humans.
- Author
-
Smart K, Cox SML, Kostikov A, Shalai A, Scala SG, Tippler M, Jaworska N, Boivin M, Séguin JR, Benkelfat C, and Leyton M
- Subjects
- Female, Humans, Male, Positron-Emission Tomography, Protein Binding, Receptor, Metabotropic Glutamate 5 metabolism, Stereoisomerism, Young Adult, Carbon Radioisotopes, Oximes chemistry, Oximes metabolism, Pyridines chemistry, Pyridines metabolism
- Abstract
Purpose: To determine how the low-affinity (Z)-isomer of the radiotracer [
11 C]ABP688 affects binding potential values in vivo in humans., Methods: High-resolution [11 C]ABP688 PET scans were acquired on 74 healthy volunteers (25 male, 49 female, mean age 20 ± 3.0). The relative contents of (E)- and (Z)-isomers were determined prior to injection using analytical high-performance liquid chromatography [rt (E) = 10 min, rt (Z) = 8.5 min]. Mean binding potential [BPND = fND * (Bavail /KD )] values were calculated in the striatum, limbic regions, and prefrontal cortex using the simplified reference tissue model with cerebellar grey matter as reference., Results: Mean ± SD (E)-isomer content in [11 C]ABP688 production was 92 ± 3.8% (range 78-97%). Percent (E)-isomer was positively correlated with BPND in the striatum (ρ = 0.28, p = 0.015) and limbic regions (ρ = 0.25, p = 0.036). In multiple regression analysis, sex (β = 0.39, p = 0.001) and (E)-isomer content (β = 0.23, p = 0.040) were significant predictors of BPND ., Conclusions: Even modest levels of (Z)-[11 C]ABP688 can reduce estimates of tracer binding in vivo. Future studies should use production methods that enrich levels of (E)-[11 C]ABP688, report tracer isomer ratios, and account for this factor in their analyses.- Published
- 2019
- Full Text
- View/download PDF
126. Why Is Aging a Risk Factor for Cognitive Impairment in Parkinson's Disease?-A Resting State fMRI Study.
- Author
-
Nagano-Saito A, Bellec P, Hanganu A, Jobert S, Mejia-Constain B, Degroot C, Lafontaine AL, Lissemore JI, Smart K, Benkelfat C, and Monchi O
- Abstract
Using resting-state functional MRI (rsfMRI) data of younger and older healthy volunteers and patients with Parkinson's disease (PD) with and without mild cognitive impairment (MCI) and applying two different analytic approaches, we investigated the effects of age, pathology, and cognition on brain connectivity. When comparing rsfMRI connectivity strength of PD patients and older healthy volunteers, reduction between multiple brain regions in PD patients with MCI (PD-MCI) compared with PD patients without MCI (PD-non-MCI) was observed. This group difference was not affected by the number and location of clusters but was reduced when age was included as a covariate. Next, we applied a graph-theory method with a cost-threshold approach to the rsfMRI data from patients with PD with and without MCI as well as groups of younger and older healthy volunteers. We observed decreased hub function (measured by degree and betweenness centrality) mainly in the medial prefrontal cortex (mPFC) in older healthy volunteers compared with younger healthy volunteers. We also found increased hub function in the posterior medial structure (precuneus and the cingulate cortex) in PD-non-MCI patients compared with older healthy volunteers and PD-MCI patients. Hub function in these posterior medial structures was positively correlated with cognitive function in all PD patients. Together these data suggest that overlapping patterns of hub modifications could mediate the effect of age as a risk factor for cognitive decline in PD, including age-related reduction of hub function in the mPFC, and recruitment availability of the posterior medial structure, possibly to compensate for impaired basal ganglia function.
- Published
- 2019
- Full Text
- View/download PDF
127. Neural function in DCC mutation carriers with and without mirror movements.
- Author
-
Vosberg DE, Beaulé V, Torres-Berrío A, Cooke D, Chalupa A, Jaworska N, Cox SML, Larcher K, Zhang Y, Allard D, Durand F, Dagher A, Benkelfat C, Srour M, Tampieri D, La Piana R, Joober R, Lepore F, Rouleau G, Pascual-Leone A, Fox MD, Flores C, Leyton M, and Théoret H
- Subjects
- Adult, Brain diagnostic imaging, Cerebellum diagnostic imaging, Cerebellum physiopathology, Corpus Callosum diagnostic imaging, Corpus Callosum physiopathology, DCC Receptor metabolism, Electromyography, Evoked Potentials, Motor physiology, Female, Functional Laterality, Functional Neuroimaging, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Motor Cortex diagnostic imaging, Motor Cortex physiopathology, Movement, Movement Disorders genetics, Mutation, Pyramidal Tracts diagnostic imaging, Pyramidal Tracts physiopathology, Transcranial Magnetic Stimulation, Young Adult, Brain physiopathology, DCC Receptor genetics, Heterozygote, Movement Disorders physiopathology, RNA, Messenger metabolism
- Abstract
Objective: Recently identified mutations of the axon guidance molecule receptor gene, DCC, present an opportunity to investigate, in living human brain, mechanisms affecting neural connectivity and the basis of mirror movements, involuntary contralateral responses that mirror voluntary unilateral actions. We hypothesized that haploinsufficient DCC
+/- mutation carriers with mirror movements would exhibit decreased DCC mRNA expression, a functional ipsilateral corticospinal tract, greater "mirroring" motor representations, and reduced interhemispheric inhibition. DCC+/- mutation carriers without mirror movements might exhibit some of these features., Methods: The participants (n = 52) included 13 DCC+/- mutation carriers with mirror movements, 7 DCC+/- mutation carriers without mirror movements, 13 relatives without the mutation or mirror movements, and 19 unrelated healthy volunteers. The multimodal approach comprised quantitative real time polymerase chain reaction, transcranial magnetic stimulation (TMS), functional magnetic resonance imaging (fMRI) under resting and task conditions, and measures of white matter integrity., Results: Mirror movements were associated with reduced DCC mRNA expression, increased ipsilateral TMS-induced motor evoked potentials, increased fMRI responses in the mirroring M1 and cerebellum, and markedly reduced interhemispheric inhibition. The DCC+/- mutation, irrespective of mirror movements, was associated with reduced functional connectivity and white matter integrity., Interpretation: Diverse connectivity abnormalities were identified in mutation carriers with and without mirror movements, but corticospinal effects and decreased peripheral DCC mRNA appeared driven by the mirror movement phenotype. ANN NEUROL 2019;85:433-442., (© 2019 The Authors. Annals of Neurology published by Wiley Periodicals, Inc. on behalf of American Neurological Association.)- Published
- 2019
- Full Text
- View/download PDF
128. Test-retest variability of [ 11 C]ABP688 estimates of metabotropic glutamate receptor subtype 5 availability in humans.
- Author
-
Smart K, Cox SML, Nagano-Saito A, Rosa-Neto P, Leyton M, and Benkelfat C
- Subjects
- Adult, Analysis of Variance, Brain drug effects, Brain Mapping, Carbon Radioisotopes pharmacokinetics, Female, Healthy Volunteers, Humans, Male, Positron-Emission Tomography, Protein Binding drug effects, Reproducibility of Results, Young Adult, Brain diagnostic imaging, Excitatory Amino Acid Antagonists pharmacokinetics, Oximes pharmacokinetics, Pyridines pharmacokinetics, Receptor, Metabotropic Glutamate 5 metabolism
- Abstract
[
11 C]ABP688 is a positron emission tomography (PET) radioligand that binds selectively to metabotropic glutamate type 5 receptors (mGluR5). The use of this tracer has identified receptor binding changes in clinical populations, and has been informative in drug occupancy studies. However, previous studies have found significant increases in [11 C]ABP688 binding in the later scan of same-day comparisons, and estimates of test-retest reliability under consistent scanning conditions are not available. The objective of this study was to assess the variability of [11 C]ABP688 binding in healthy people in scans performed at the same time of day. Two [11 C]ABP688 scans were acquired in eight healthy volunteers (6 women, 2 men) using a high-resolution research tomograph (HRRT). Scans were acquired 3 weeks apart with start times between 10:00am and 1:30pm. Mean mGluR5 binding potential (BPND ) values were calculated across cortical, striatal and limbic brain regions. Participants reported on subjective mood state after each scan and blood samples were drawn for cortisol analysis. No significant change in BPND between scans was observed. Variability in BPND values of 11-21% was observed across regions, with the greatest change in the hippocampus and amygdala. Reliability was low to moderate. BPND was not statistically related to scan start time, subjective anxiety, serum cortisol levels, or menstrual phase in women. Overall, [11 C]ABP688 BPND estimates show moderate variability in healthy people. Reliability is fair in cortical and striatal regions, and lower in limbic regions. Future research using this ligand should account for this in study design and analysis., (© 2018 Wiley Periodicals, Inc.)- Published
- 2018
- Full Text
- View/download PDF
129. Mesocorticolimbic Connectivity and Volumetric Alterations in DCC Mutation Carriers.
- Author
-
Vosberg DE, Zhang Y, Menegaux A, Chalupa A, Manitt C, Zehntner S, Eng C, DeDuck K, Allard D, Durand F, Dagher A, Benkelfat C, Srour M, Joober R, Lepore F, Rouleau G, Théoret H, Bedell BJ, Flores C, and Leyton M
- Subjects
- Adult, Aging psychology, Animals, Axons, Exploratory Behavior, Female, Heterozygote, Humans, Limbic System diagnostic imaging, Magnetic Resonance Imaging, Male, Mice, Mice, Inbred C57BL, Mice, Transgenic, Middle Aged, Neural Pathways diagnostic imaging, Personality Disorders genetics, Personality Disorders psychology, Prefrontal Cortex diagnostic imaging, Substance-Related Disorders genetics, Substance-Related Disorders psychology, Substantia Nigra diagnostic imaging, Substantia Nigra physiopathology, Ventral Tegmental Area diagnostic imaging, Ventral Tegmental Area physiopathology, Young Adult, DCC Receptor genetics, Limbic System physiopathology, Neural Pathways physiopathology, Prefrontal Cortex physiopathology
- Abstract
The axon guidance cue receptor DCC (deleted in colorectal cancer) plays a critical role in the organization of mesocorticolimbic pathways in rodents. To investigate whether this occurs in humans, we measured (1) anatomical connectivity between the substantia nigra/ventral tegmental area (SN/VTA) and forebrain targets, (2) striatal and cortical volumes, and (3) putatively associated traits and behaviors. To assess translatability, morphometric data were also collected in Dcc -haploinsufficient mice. The human volunteers were 20 DCC
+/- mutation carriers, 16 DCC+/+ relatives, and 20 DCC+/+ unrelated healthy volunteers (UHVs; 28 females). The mice were 11 Dcc+/- and 16 wild-type C57BL/6J animals assessed during adolescence and adulthood. Compared with both control groups, the human DCC+/- carriers exhibited the following: (1) reduced anatomical connectivity from the SN/VTA to the ventral striatum [ DCC+/+ : p = 0.0005, r ( effect size ) = 0.60; UHV: p = 0.0029, r = 0.48] and ventral medial prefrontal cortex ( DCC+/+ : p = 0.0031, r = 0.53; UHV: p = 0.034, r = 0.35); (2) lower novelty-seeking scores ( DCC+/+ : p = 0.034, d = 0.82; UHV: p = 0.019, d = 0.84); and (3) reduced striatal volume ( DCC+/+ : p = 0.0009, d = 1.37; UHV: p = 0.0054, d = 0.93). Striatal volumetric reductions were also present in Dcc+/- mice, and these were seen during adolescence ( p = 0.0058, d = 1.09) and adulthood ( p = 0.003, d = 1.26). Together these findings provide the first evidence in humans that an axon guidance gene is involved in the formation of mesocorticolimbic circuitry and related behavioral traits, providing mechanisms through which DCC mutations might affect susceptibility to diverse neuropsychiatric disorders. SIGNIFICANCE STATEMENT Opportunities to study the effects of axon guidance molecules on human brain development have been rare. Here, the identification of a large four-generational family that carries a mutation to the axon guidance molecule receptor gene, DCC , enabled us to demonstrate effects on mesocorticolimbic anatomical connectivity, striatal volumes, and personality traits. Reductions in striatal volumes were replicated in DCC -haploinsufficient mice. Together, these processes might influence mesocorticolimbic function and susceptibility to diverse neuropsychiatric disorders., (Copyright © 2018 the authors 0270-6474/18/384655-11$15.00/0.)- Published
- 2018
- Full Text
- View/download PDF
130. Brain serotonin synthesis capacity in obsessive-compulsive disorder: effects of cognitive behavioral therapy and sertraline.
- Author
-
Lissemore JI, Sookman D, Gravel P, Berney A, Barsoum A, Diksic M, Nordahl TE, Pinard G, Sibon I, Cottraux J, Leyton M, and Benkelfat C
- Subjects
- Adult, Brain diagnostic imaging, Combined Modality Therapy, Female, Humans, Male, Middle Aged, Obsessive-Compulsive Disorder diagnostic imaging, Positron-Emission Tomography, Treatment Outcome, Young Adult, Brain metabolism, Cognitive Behavioral Therapy, Obsessive-Compulsive Disorder drug therapy, Obsessive-Compulsive Disorder metabolism, Serotonin biosynthesis, Selective Serotonin Reuptake Inhibitors therapeutic use, Sertraline therapeutic use
- Abstract
Cognitive behavioral therapy (CBT) and selective serotonin reuptake inhibitors (SSRIs) are both effective treatments for some patients with obsessive-compulsive disorder (OCD), yet little is known about the neurochemical changes related to these treatment modalities. Here, we used positron emission tomography and the α-[
11 C]methyl-L-tryptophan tracer to examine the changes in brain regional serotonin synthesis capacity in OCD patients following treatment with CBT or SSRI treatment. Sixteen medication-free OCD patients were randomly assigned to 12 weeks of either CBT or sertraline treatment. Pre-to-post treatment changes in the α-[11 C]methyl-L-tryptophan brain trapping constant, K* (ml/g/min), were assessed as a function of symptom response, and correlations with symptom improvement were examined. Responders/partial responders to treatment did not show significant changes in relative regional tracer uptake; rather, in responders/partial responders, 12 weeks of treatment led to serotonin synthesis capacity increases that were brain-wide. Irrespective of treatment modality, baseline serotonin synthesis capacity in the raphe nuclei correlated positively with clinical improvement. These observations suggest that, for some patients, successful remediation of OCD symptoms might be associated with greater serotonergic tone.- Published
- 2018
- Full Text
- View/download PDF
131. Posterior dopamine D2/3 receptors and brain network functional connectivity.
- Author
-
Nagano-Saito A, Lissemore JI, Gravel P, Leyton M, Carbonell F, and Benkelfat C
- Subjects
- Adult, Benzamides, Brain diagnostic imaging, Brain Mapping, Female, Humans, Magnetic Resonance Imaging, Male, Multimodal Imaging, Neural Pathways diagnostic imaging, Neural Pathways metabolism, Positron-Emission Tomography, Pyrrolidines, Radiopharmaceuticals, Rest, Young Adult, Brain metabolism, Receptors, Dopamine D2 metabolism, Receptors, Dopamine D3 metabolism
- Abstract
Recent studies suggest that dopaminergic tone influences resting state activity in multiple brain networks. Although dopamine receptors and transporters have been identified in the posteromedial and parietal cortices, which are linked to functional networks such as the default mode network (DMN), the relationship between dopamine receptor distribution in these posterior regions and resting-state connectivity has yet to be explored. Here, we used a multi-modal neuroimaging strategy, combining resting-state functional magnetic resonance imaging (rsfMRI) and [18 F]-fallypride high-resolution positron emission tomography (PET), to examine the association between within-network functional connectivity and the dopamine D2/3 receptor distribution in the posterior portion of the brain in 13 healthy adults. Our results indicate that the posterior distribution of D2/3 receptors coincides primarily with the posterior portion of the DMN. Furthermore, in the posterior portion of the brain, the level of [18 F]-fallypride binding in the posteromedial cortex correlated positively with the functional connectivity strength of the DMN and sensorimotor network, and negatively with the functional connectivity strength of the dorsal attention network, the salience network, and a network that included the anterior part of the temporo-parietal junction. On the basis of these findings, we propose that posterior brain dopamine influences the configuration of the posterior DMN and several other functional brain networks. The posterior distribution of D2/3 receptors binding (hot colour spectrum) coincides with the functional connectivity of the posterior portion of the default mode network (green colour spectrum). The mean BP
ND in a posteromedial cortex and the mean ICA-Z score in the precuneus showed significant positive correlation., (© 2017 Wiley Periodicals, Inc.)- Published
- 2017
- Full Text
- View/download PDF
132. Dopamine and light: effects on facial emotion recognition.
- Author
-
Cawley E, Tippler M, Coupland NJ, Benkelfat C, Boivin DB, Aan Het Rot M, and Leyton M
- Subjects
- Adult, Affect drug effects, Double-Blind Method, Female, Humans, Light, Male, Phenylalanine therapeutic use, Reaction Time drug effects, Seasonal Affective Disorder drug therapy, Tyrosine therapeutic use, Young Adult, Dopamine therapeutic use, Emotions drug effects, Face physiology
- Abstract
Bright light can affect mood states and social behaviours. Here, we tested potential interacting effects of light and dopamine on facial emotion recognition. Participants were 32 women with subsyndromal seasonal affective disorder tested in either a bright (3000 lux) or dim light (10 lux) environment. Each participant completed two test days, one following the ingestion of a phenylalanine/tyrosine-deficient mixture and one with a nutritionally balanced control mixture, both administered double blind in a randomised order. Approximately four hours post-ingestion participants completed a self-report measure of mood followed by a facial emotion recognition task. All testing took place between November and March when seasonal symptoms would be present. Following acute phenylalanine/tyrosine depletion (APTD), compared to the nutritionally balanced control mixture, participants in the dim light condition were more accurate at recognising sad faces, less likely to misclassify them, and faster at responding to them, effects that were independent of changes in mood. Effects of APTD on responses to sad faces in the bright light group were less consistent. There were no APTD effects on responses to other emotions, with one exception: a significant light × mixture interaction was seen for the reaction time to fear, but the pattern of effect was not predicted a priori or seen on other measures. Together, the results suggest that the processing of sad emotional stimuli might be greater when dopamine transmission is low. Bright light exposure, used for the treatment of both seasonal and non-seasonal mood disorders, might produce some of its benefits by preventing this effect.
- Published
- 2017
- Full Text
- View/download PDF
133. Differential Associations between Cortical Thickness and Striatal Dopamine in Treatment-Naïve Adults with ADHD vs. Healthy Controls.
- Author
-
Cherkasova MV, Faridi N, Casey KF, Larcher K, O'Driscoll GA, Hechtman L, Joober R, Baker GB, Palmer J, Evans AC, Dagher A, Benkelfat C, and Leyton M
- Abstract
Alterations in catecholamine signaling and cortical morphology have both been implicated in the pathophysiology of attention deficit/hyperactivity disorder (ADHD). However, possible links between the two remain unstudied. Here, we report exploratory analyses of cortical thickness and its relation to striatal dopamine transmission in treatment-naïve adults with ADHD and matched healthy controls. All participants had one magnetic resonance imaging (MRI) and two [
11 C]raclopride positron emission tomography scans. Associations between frontal cortical thickness and the magnitude of d -amphetamine-induced [11 C]raclopride binding changes were observed that were divergent in the two groups. In the healthy controls, a thicker cortex was associated with less dopamine release; in the ADHD participants the converse was seen. The same divergence was seen for baseline D2/3 receptor availability. In healthy volunteers, lower D2/3 receptor availability was associated with a thicker cortex, while in the ADHD group lower baseline D2/3 receptor availability was associated with a thinner cortex. Individual differences in cortical thickness in these regions correlated with ADHD symptom severity. Together, these findings add to the evidence of associations between dopamine transmission and cortical morphology, and suggest that these relationships are altered in treatment-naïve adults with ADHD.- Published
- 2017
- Full Text
- View/download PDF
134. Cocaine Cue-Induced Dopamine Release in Recreational Cocaine Users.
- Author
-
Cox SML, Yau Y, Larcher K, Durand F, Kolivakis T, Delaney JS, Dagher A, Benkelfat C, and Leyton M
- Subjects
- Adolescent, Adult, Behavior, Addictive diagnostic imaging, Carbon Radioisotopes chemistry, Cocaine-Related Disorders diagnostic imaging, Corpus Striatum diagnostic imaging, Corpus Striatum metabolism, Cues, Dopamine Uptake Inhibitors pharmacology, Humans, Male, Positron-Emission Tomography methods, Raclopride chemistry, Surveys and Questionnaires, Young Adult, Cocaine pharmacology, Corpus Striatum drug effects, Dopamine metabolism, Drug-Seeking Behavior drug effects
- Abstract
It has been proposed that the acquisition of drug seeking is related to the development of conditioned dopamine responses in the ventral striatum. As drug use continues and becomes habit-like, conditioned responses have been shown to shift to the dorsal striatum. Here, using the PET [
11 C]raclopride method and highly personalized cocaine cues, we report the first evidence in humans of the dorsal dopamine response prior to the onset of addiction.- Published
- 2017
- Full Text
- View/download PDF
135. Is there a relation between novelty seeking, striatal dopamine release and frontal cortical thickness?
- Author
-
Jaworska N, Cox SM, Casey KF, Boileau I, Cherkasova M, Larcher K, Dagher A, Benkelfat C, and Leyton M
- Subjects
- Adult, Female, Frontal Lobe anatomy & histology, Humans, Magnetic Resonance Imaging, Male, Organ Size, Positron-Emission Tomography, Young Adult, Corpus Striatum physiology, Dopamine metabolism, Exploratory Behavior, Frontal Lobe physiology
- Abstract
Background: Novelty-seeking (NS) and impulsive personality traits have been proposed to reflect an interplay between fronto-cortical and limbic systems, including the limbic striatum (LS). Although neuroimaging studies have provided some evidence for this, most are comprised of small samples and many report surprisingly large effects given the challenges of trying to relate a snapshot of brain function or structure to an entity as complex as personality. The current work tested a priori hypotheses about associations between striatal dopamine (DA) release, cortical thickness (CT), and NS in a large sample of healthy adults., Methods: Fifty-two healthy adults (45M/7F; age: 23.8±4.93) underwent two positron emission tomography scans with [11C]raclopride (specific for striatal DA D2/3 receptors) with or without amphetamine (0.3 mg/kg, p.o.). Structural magnetic resonance image scans were acquired, as were Tridimensional Personality Questionnaire data. Amphetamine-induced changes in [11C]raclopride binding potential values (ΔBPND) were examined in the limbic, sensorimotor (SMS) and associative (AST) striatum. CT measures, adjusted for whole brain volume, were extracted from the dorsolateral sensorimotor and ventromedial/limbic cortices., Results: BPND values were lower in the amphetamine vs. no-drug sessions, with the largest effect in the LS. When comparing low vs. high LS ΔBPND groups (median split), higher NS2 (impulsiveness) scores were found in the high ΔBPND group. Partial correlations (age and gender as covariates) yielded a negative relation between ASTS ΔBPND and sensorimotor CT; trends for inverse associations existed between ΔBPND values in other striatal regions and frontal CT. In other words, the greater the amphetamine-induced striatal DA response, the thinner the frontal cortex., Conclusions: These data expand upon previously reported associations between striatal DA release in the LS and both NS related impulsiveness and CT in the largest sample reported to date. The findings add to the plausibility of these associations while suggesting that the effects are likely weaker than has been previously proposed.
- Published
- 2017
- Full Text
- View/download PDF
136. Cocaine cue-induced dopamine release in the human prefrontal cortex.
- Author
-
Milella MS, Fotros A, Gravel P, Casey KF, Larcher K, Verhaeghe JA, Cox SM, Reader AJ, Dagher A, Benkelfat C, and Leyton M
- Subjects
- Adult, Benzamides, Brain Mapping, Cocaine administration & dosage, Cocaine-Related Disorders diagnostic imaging, Cocaine-Related Disorders psychology, Corpus Striatum diagnostic imaging, Corpus Striatum metabolism, Cues, Dopamine D2 Receptor Antagonists, Dopamine Uptake Inhibitors administration & dosage, Female, Fluorine Radioisotopes, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neuropsychological Tests, Positron-Emission Tomography, Prefrontal Cortex diagnostic imaging, Radiopharmaceuticals, Cocaine-Related Disorders metabolism, Craving physiology, Dopamine metabolism, Prefrontal Cortex metabolism
- Abstract
Background: Accumulating evidence indicates that drug-related cues can induce dopamine (DA) release in the striatum of substance abusers. Whether these same cues provoke DA release in the human prefrontal cortex remains unknown., Methods: We used high-resolution positron emission tomography with [18F]fallypride to measure cortical and striatal DA D2/3 receptor availability in the presence versus absence of drug-related cues in volunteers with current cocaine dependence., Results: Twelve individuals participated in our study. Among participants reporting a craving response (9 of 12), exposure to the cocaine cues significantly decreased [18F]fallypride binding potential (BPND) values in the medial orbitofrontal cortex and striatum. In all 12 participants, individual differences in the magnitude of craving correlated with BPND changes in the medial orbitofrontal cortex, dorsolateral prefrontal cortex, anterior cingulate, and striatum. Consistent with the presence of autoreceptors on mesostriatal but not mesocortical DA cell bodies, midbrain BPND values were significantly correlated with changes in BPND within the striatum but not the cortex. The lower the midbrain D2 receptor levels, the greater the striatal change in BPND and self-reported craving., Limitations: Limitations of this study include its modest sample size, with only 2 female participants. Newer tracers might have greater sensitivity to cortical DA release., Conclusion: In people with cocaine use disorders, the presentation of drug-related cues induces DA release within cortical and striatal regions. Both effects are associated with craving, but only the latter is regulated by midbrain autoreceptors. Together, the results suggest that cortical and subcortical DA responses might both influence drug-focused incentive motivational states, but with separate regulatory mechanisms.
- Published
- 2016
- Full Text
- View/download PDF
137. Genetic and early environmental influences on the serotonin system: consequences for brain development and risk for psychopathology.
- Author
-
Booij L, Tremblay RE, Szyf M, and Benkelfat C
- Subjects
- Animals, Environment, Epigenesis, Genetic, Genetic Predisposition to Disease, Humans, Brain growth & development, Brain physiopathology, Gene-Environment Interaction, Mental Disorders physiopathology, Serotonin genetics, Serotonin metabolism
- Abstract
Background: Despite more than 60 years of research in the role of serotonin (5-HT) in psychopathology, many questions still remain. From a developmental perspective, studies have provided more insight into how 5-HT dysfunctions acquired in utero or early in life may modulate brain development. This paper discusses the relevance of the developmental role of 5-HT for the understanding of psychopathology. We review developmental milestones of the 5-HT system, how genetic and environmental 5-HT disturbances could affect brain development and the potential role of DNA methylation in 5-HT genes for brain development., Methods: Studies were identified using common databases (e.g., PubMed, Google Scholar) and reference lists., Results: Despite the widely supported view that the 5-HT system matures in early life, different 5-HT receptors, proteins and enzymes have different developmental patterns, and development is brain region-specific. A disruption in 5-HT homeostasis during development may lead to structural and functional changes in brain circuits that modulate emotional stress responses, including subcortical limbic and (pre)frontal areas. This may result in a predisposition to psychopathology. DNA methylation might be one of the underlying physiologic mechanisms., Limitations: There is a need for prospective studies. The impact of stressors during adolescence on the 5-HT system is understudied. Questions regarding efficacy of drugs acting on 5-HT still remain., Conclusion: A multidisciplinary and longitudinal approach in designing studies on the role of 5-HT in psychopathology might help to bring us closer to the understanding of the role of 5-HT in psychopathology.
- Published
- 2015
- Full Text
- View/download PDF
138. Brain serotonin synthesis in MDMA (ecstasy) polydrug users: an alpha-[(11) C]methyl-l-tryptophan study.
- Author
-
Booij L, Soucy JP, Young SN, Regoli M, Gravel P, Diksic M, Leyton M, Pihl RO, and Benkelfat C
- Subjects
- Adult, Antidepressive Agents, Second-Generation blood, Antidepressive Agents, Second-Generation pharmacology, Brain diagnostic imaging, Brain metabolism, Brain Mapping, Female, Humans, Male, Positron-Emission Tomography, Self Report, Sex Factors, Substance-Related Disorders diagnostic imaging, Tryptophan blood, Tryptophan pharmacology, Young Adult, Brain drug effects, N-Methyl-3,4-methylenedioxyamphetamine adverse effects, Serotonin metabolism, Substance-Related Disorders pathology, Tryptophan analogs & derivatives
- Abstract
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) use may have long-term neurotoxic effects. In this study, positron emission tomography with the tracer alpha-[(11) C]methyl-l-tryptophan ((11) C-AMT) was used to compare human brain serotonin (5-HT) synthesis capacity in 17 currently drug-free MDMA polydrug users with that in 18 healthy matched controls. Gender differences and associations between regional (11) C-AMT trapping and characteristics of MDMA use were also examined. MDMA polydrug users exhibited lower normalized (11) C-AMT trapping in pre-frontal, orbitofrontal, and parietal regions, relative to controls. These differences were more widespread in males than in females. Increased normalized (11) C-AMT trapping in MDMA users was also observed, mainly in the brainstem and in frontal and temporal areas. Normalized (11) C-AMT trapping in the brainstem and pre-frontal regions correlated positively and negatively, respectively, with greater lifetime accumulated MDMA use, longer durations of MDMA use, and shorter time elapsed since the last MDMA use. Although the possibility of pre-existing 5-HT alterations pre-disposing people to use MDMA cannot be ruled out, regionally decreased 5-HT synthesis capacity in the forebrain could be interpreted as neurotoxicity of MDMA on distal (frontal) brain regions. On the other hand, increased 5-HT synthesis capacity in the raphe and adjacent areas could be due to compensatory mechanisms., (© 2014 International Society for Neurochemistry.)
- Published
- 2014
- Full Text
- View/download PDF
139. Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study.
- Author
-
Milella MS, Marengo L, Larcher K, Fotros A, Dagher A, Rosa-Neto P, Benkelfat C, and Leyton M
- Subjects
- Adult, Brain diagnostic imaging, Carbon Radioisotopes, Cocaine-Related Disorders diagnostic imaging, Female, Humans, Limbic System diagnostic imaging, Male, Oximes, Positron-Emission Tomography, Pyridines, Receptor, Metabotropic Glutamate 5 antagonists & inhibitors, Brain metabolism, Cocaine-Related Disorders metabolism, Limbic System metabolism, Receptor, Metabotropic Glutamate 5 metabolism
- Abstract
Cocaine self-administration decreases type 5 metabotropic glutamate receptor (mGluR5) tissue concentrations in laboratory rats during early abstinence. These changes are thought to influence the drug's reinforcing properties and the ability of drug-related cues to induce relapse. Here, our goal was to measure brain regional mGluR5 availability in recently abstinent cocaine dependent humans. Participants meeting DSM-IV diagnostic criteria for current cocaine dependence (n=9) were recruited from the general population. mGluR5 availability (binding potential, non-displaceable; BPND) was measured with high-resolution positron emission tomography (PET HRRT) and [(11)C]ABP688. Compared to age- and sex-matched healthy controls (n=9), cocaine dependent subjects showed significantly lower BPND values in the ventral (bilateral: -28.2%, p=0.011), associative (right: -21.4%, p=0.043), and sensorimotor striatum (bilateral: -21.7%, p=0.045), amygdala (left: -26%, p=0.046) and insula (right: -23.3%, p=0.041). Among the cocaine users, receptor availabilities were related to abstinence (range: 2 to 14days). The longer the duration of abstinence, the lower the BPND values in the sensorimotor striatum (r=-0.71, p=0.034), left amygdala (r=-0.73, p=0.026) and right insula (r=-0.67, p=0.046). Compared to healthy controls, BPND values were significantly reduced in those who tested negative for cocaine on the PET test session in the ventral (p=0.018) and sensorimotor striatum (p=0.017), left amygdala (p=0.008), and right insula (p=0.029), but not in those who tested positive. Together, these results provide evidence of time-related mGluR5 alterations in striatal and limbic regions in humans during early cocaine abstinence., (Copyright © 2014 Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
140. Dopamine precursor depletion impairs structure and efficiency of resting state brain functional networks.
- Author
-
Carbonell F, Nagano-Saito A, Leyton M, Cisek P, Benkelfat C, He Y, and Dagher A
- Subjects
- Adult, Algorithms, Amino Acids blood, Brain Mapping methods, Double-Blind Method, Female, Humans, Magnetic Resonance Imaging methods, Male, Models, Neurological, Neural Pathways physiology, Phenylalanine blood, Rest, Signal Processing, Computer-Assisted, Tyrosine blood, Young Adult, Amino Acids administration & dosage, Brain physiology, Dopamine metabolism, Phenylalanine deficiency, Tyrosine deficiency
- Abstract
Spatial patterns of functional connectivity derived from resting brain activity may be used to elucidate the topological properties of brain networks. Such networks are amenable to study using graph theory, which shows that they possess small world properties and can be used to differentiate healthy subjects and patient populations. Of particular interest is the possibility that some of these differences are related to alterations in the dopamine system. To investigate the role of dopamine in the topological organization of brain networks at rest, we tested the effects of reducing dopamine synthesis in 13 healthy subjects undergoing functional magnetic resonance imaging. All subjects were scanned twice, in a resting state, following ingestion of one of two amino acid drinks in a randomized, double-blind manner. One drink was a nutritionally balanced amino acid mixture, and the other was tyrosine and phenylalanine deficient. Functional connectivity between 90 cortical and subcortical regions was estimated for each individual subject under each dopaminergic condition. The lowered dopamine state caused the following network changes: reduced global and local efficiency of the whole brain network, reduced regional efficiency in limbic areas, reduced modularity of brain networks, and greater connection between the normally anti-correlated task-positive and default-mode networks. We conclude that dopamine plays a role in maintaining the efficient small-world properties and high modularity of functional brain networks, and in segregating the task-positive and default-mode networks. This article is part of the Special Issue Section entitled 'Neuroimaging in Neuropharmacology'., (Copyright © 2014 Elsevier Ltd. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
141. Reduced dopamine response to amphetamine in subjects at ultra-high risk for addiction.
- Author
-
Casey KF, Benkelfat C, Cherkasova MV, Baker GB, Dagher A, and Leyton M
- Subjects
- Case-Control Studies, Central Nervous System Stimulants pharmacology, Corpus Striatum diagnostic imaging, Corpus Striatum metabolism, Dopamine Antagonists, Female, Functional Neuroimaging, Humans, Male, Positron-Emission Tomography, Prodromal Symptoms, Raclopride, Substance-Related Disorders diagnostic imaging, Young Adult, Amphetamine pharmacology, Dopamine metabolism, Family Health, Substance-Related Disorders diagnosis
- Abstract
Background: Not everyone who tries addictive drugs develops a substance use disorder. One of the best predictors of risk is a family history (FH) of substance use problems. In part, this might reflect perturbed mesolimbic dopamine responses., Methods: We measured amphetamine-induced changes in [(11)C]raclopride binding in 1) high-risk young adults with a multigenerational FH of substance use disorders (n = 16); 2) stimulant drug-naïve healthy control subjects with no known risk factors for addiction (n = 17); and 3) subjects matched to the high-risk group on personal drug use but without a FH of substance use problems (n = 15)., Results: Compared with either control group, the high-risk young adults with a multigenerational FH of substance use disorders exhibited smaller [(11)C]raclopride responses, particularly within the right ventral striatum. Past drug use predicted the dopamine response also, but including it as a covariate increased the group differences., Conclusions: Together, the results suggest that young people at familial high risk for substance use disorders have decreased dopamine responses to an amphetamine challenge, an effect that predates the onset of addiction., (© 2013 Society of Biological Psychiatry Published by Society of Biological Psychiatry All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
142. Amphetamine-induced dopamine release and neurocognitive function in treatment-naive adults with ADHD.
- Author
-
Cherkasova MV, Faridi N, Casey KF, O'Driscoll GA, Hechtman L, Joober R, Baker GB, Palmer J, Dagher A, Leyton M, and Benkelfat C
- Subjects
- Adult, Attention Deficit Disorder with Hyperactivity psychology, Brain Mapping, Corpus Striatum diagnostic imaging, Dextroamphetamine blood, Dopamine Antagonists pharmacokinetics, Dopamine Uptake Inhibitors blood, Executive Function physiology, Humans, Inhibition, Psychological, Male, Neuropsychological Tests, Psychiatric Status Rating Scales, Raclopride pharmacokinetics, Radionuclide Imaging, Task Performance and Analysis, Attention Deficit Disorder with Hyperactivity drug therapy, Attention Deficit Disorder with Hyperactivity metabolism, Corpus Striatum metabolism, Dextroamphetamine pharmacology, Dopamine metabolism, Dopamine Uptake Inhibitors pharmacology
- Abstract
Converging evidence from clinical, preclinical, neuroimaging, and genetic research implicates dopamine neurotransmission in the pathophysiology of attention deficit hyperactivity disorder (ADHD). The in vivo neuroreceptor imaging evidence also suggests alterations in the dopamine system in ADHD; however, the nature and behavioral significance of those have not yet been established. Here, we investigated striatal dopaminergic function in ADHD using [(11)C]raclopride PET with a d-amphetamine challenge. We also examined the relationship of striatal dopamine responses to ADHD symptoms and neurocognitive function. A total of 15 treatment-free, noncomorbid adult males with ADHD (age: 29.87 ± 8.65) and 18 healthy male controls (age: 25.44 ± 6.77) underwent two PET scans: one following a lactose placebo and the other following d-amphetamine (0.3 mg/kg, p.o.), administered double blind and in random order counterbalanced across groups. In a separate session without a drug, participants performed a battery of neurocognitive tests. Relative to the healthy controls, the ADHD patients, as a group, showed greater d-amphetamine-induced decreases in striatal [(11)C]raclopride binding and performed more poorly on measures of response inhibition. Across groups, a greater magnitude of d-amphetamine-induced change in [(11)C]raclopride binding potential was associated with poorer performance on measures of response inhibition and ADHD symptoms. Our findings suggest an augmented striatal dopaminergic response in treatment-naive ADHD. Though in contrast to results of a previous study, this finding appears consistent with a model proposing exaggerated phasic dopamine release in ADHD. A susceptibility to increased phasic dopamine responsivity may contribute to such characteristics of ADHD as poor inhibition and impulsivity.
- Published
- 2014
- Full Text
- View/download PDF
143. The effect of acute tryptophan depletion on mood and impulsivity in polydrug ecstasy users.
- Author
-
Young SN, Regoli M, Leyton M, Pihl RO, and Benkelfat C
- Subjects
- Amphetamine-Related Disorders blood, Amphetamine-Related Disorders psychology, Analysis of Variance, Cross-Over Studies, Diet, Double-Blind Method, Female, Humans, Impulsive Behavior blood, Impulsive Behavior metabolism, Male, Neuropsychological Tests, Sex Factors, Time Factors, Tryptophan blood, Young Adult, Affect drug effects, Affect physiology, Amphetamine-Related Disorders metabolism, N-Methyl-3,4-methylenedioxyamphetamine pharmacology, Serotonin Agents pharmacology, Tryptophan deficiency
- Abstract
Rationale: Several studies suggest users of 3,4-methylenedioxymethamphetamine (ecstasy) have low levels of serotonin. Low serotonin may make them susceptible to lowered mood., Objective: This work aims to study the acute effects on mood and impulsivity of lowering serotonin levels with acute tryptophan depletion in polydrug ecstasy users and to determine whether effects were different in men and women., Methods: In a double-blind cross-over study, participants who had used ecstasy at least 25 times (n = 13) and nonuser controls (n = 17) received a tryptophan-deficient amino acid mixture and a control amino acid mixture containing tryptophan, at least 1 week apart. Mood was measured using the profile of mood states, and impulsivity was measured with the Go/No-Go task., Results: The main result shows that a lowering of mood after acute tryptophan depletion occurred only in female polydrug ecstasy users (n = 7), relative to controls (n = 9). Results from the Go/No-Go task suggested that impulsivity was not increased by acute tryptophan depletion in polydrug ecstasy users., Limitation: The group sizes were small, when males and females were considered separately., Conclusions: Women polydrug ecstasy users appear to be more susceptible than men to the effects of lowered serotonin levels. If use of ecstasy alone or in conjunction with other drugs causes progressive damage of serotonin neurons, women polydrug ecstasy users may become susceptible to clinical depression.
- Published
- 2014
- Full Text
- View/download PDF
144. Differential striatal dopamine responses following oral alcohol in individuals at varying risk for dependence.
- Author
-
Setiawan E, Pihl RO, Dagher A, Schlagintweit H, Casey KF, Benkelfat C, and Leyton M
- Subjects
- Administration, Oral, Adolescent, Alcohol Drinking psychology, Alcoholism psychology, Biomarkers metabolism, Female, Humans, Magnetic Resonance Imaging methods, Male, Positron-Emission Tomography methods, Risk Factors, Surveys and Questionnaires, Young Adult, Alcohol Drinking metabolism, Alcoholism diagnosis, Alcoholism metabolism, Corpus Striatum metabolism, Dopamine metabolism, Individuality
- Abstract
Background: The neurobiology of risk for alcohol use disorders (AUDs) remains poorly understood. Individual differences in vulnerability, though, have been indicated by subjective responses to alcohol ingestion and personality traits., Methods: To investigate the relationship between these features and striatal dopamine (DA) responses to alcohol, we studied 26 healthy young social drinkers (21.3 ± 3.0 years old; 10.7 ± 8.8 drinks/wk) at varying risk for alcoholism. Each participant received 2 positron emission tomography [(11) C]raclopride scans after administration of either placebo or oral alcohol (1 ml/kg body weight of 94% alcohol, 0.75 g/kg) in a randomized and counterbalanced design., Results: Subjects with high-risk subjective responses to alcohol had more family members with AUDs, greater alcohol use problems, and, in response to the alcohol challenge, significant decreases in [(11) C]raclopride binding indicative of increased extracellular DA. In contrast, low-risk subjects exhibited increases in [(11) C]raclopride binding in response to alcohol. The results were similar when risk groups were based on personality traits, although statistically less robust., Conclusions: Changes in striatal DA in response to alcohol ingestion may be a neurobiological marker of vulnerability to AUDs., (Copyright © 2013 by the Research Society on Alcoholism.)
- Published
- 2014
- Full Text
- View/download PDF
145. Stress-induced dopamine release in human medial prefrontal cortex--18F-fallypride/PET study in healthy volunteers.
- Author
-
Nagano-Saito A, Dagher A, Booij L, Gravel P, Welfeld K, Casey KF, Leyton M, and Benkelfat C
- Subjects
- Adolescent, Adult, Benzamides administration & dosage, Healthy Volunteers, Heart Rate, Humans, Male, Positron-Emission Tomography, Prefrontal Cortex physiology, Pyrrolidines administration & dosage, Dopamine metabolism, Prefrontal Cortex metabolism, Stress, Psychological metabolism
- Abstract
Background: In laboratory animals, environmental stressors markedly activate the mesocortical dopamine system. The present study tested whether this occurs in humans., Methods: The effects of a laboratory psychological stressor (Montreal Imaging Stress Task, MIST) on mesocortical dopamine release in healthy young adults (11 males, mean age ± SD, 20.6 ± 2.4 years) was measured using positron emission tomography and [(18)F]fallypride. Each subject was scanned in two separate days in counterbalanced order: one with the MIST and one with the control task. Binding potential (BP ND ) maps of the whole brain were calculated for each scan, using a simplified reference tissue compartmental model. Then BP ND was compared between subjects. Heart rate, galvanic skin response, and salivary cortisol level were measured during the scans., Results: The psychological stressor significantly decreased [(18)F]fallypride binding values in the dorsal part of the medial prefrontal cortex (dmPFC), corresponding to the rostal part of the cingulate motor zone. The greater the stress-induced decrease in [(18)F]fallypride binding in the dmPFC, the greater the stress-induced increases in heart rate., Conclusions: The present study provides evidence of stress-induced dopamine release in the mPFC in humans, in vivo., (Copyright © 2013 Wiley Periodicals, Inc.)
- Published
- 2013
- Full Text
- View/download PDF
146. Dopamine and light: dissecting effects on mood and motivational states in women with subsyndromal seasonal affective disorder.
- Author
-
Cawley EI, Park S, aan het Rot M, Sancton K, Benkelfat C, Young SN, Boivin DB, and Leyton M
- Subjects
- Adult, Affect drug effects, Dopamine deficiency, Female, Humans, Motivation drug effects, Phenylalanine blood, Phenylalanine pharmacology, Psychomotor Performance drug effects, Psychomotor Performance physiology, Reward, Seasonal Affective Disorder diagnosis, Seasonal Affective Disorder metabolism, Tyrosine blood, Tyrosine pharmacology, Affect physiology, Dopamine physiology, Light, Motivation physiology, Seasonal Affective Disorder physiopathology, Seasonal Affective Disorder psychology
- Abstract
Background: Despite evidence that bright light can improve mood, the neurobiology remains poorly understood. Some evidence implicates the catecholamines. In the present study, we measured the effects of transiently decreasing dopamine (DA) synthesis on mood and motivational states in healthy women with mild seasonal mood changes who were tested in either bright or dim light., Methods: On 2 test days, participants slept overnight in a light-controlled room. On the morning of each session, half of the participants awoke to gradual increases of bright light, up to 3000 lux, and half to dim light (10 lux). For all participants, DA was reduced on 1 of the test days using the acute phenylalanine/tyrosine depletion (APTD) method; on the other day, they ingested a nutritionally balanced control mixture (BAL). Beginning 4 hours postingestion, participants completed subjective mood questionnaires, psychological tests and a progressive ratio breakpoint task during which they worked for successive units of $5., Results: Thirty-two women participated in our study. The APTD lowered mood, agreeableness, energy and the willingness to work for monetary reward. The effects on energy and motivation were independent of light, while the effects on mood and agreeableness were seen in the dim condition only, being prevented by bright light., Limitations: Acute phenylalanine/tyrosine depletion might affect systems other than DA. The sample size was small., Conclusion: These results suggest that increased DA function may be responsible for some of the beneficial effects of light, while adding to the evidence that the neurobiology of mood and motivational states can be dissociated.
- Published
- 2013
- Full Text
- View/download PDF
147. Cocaine cue-induced dopamine release in amygdala and hippocampus: a high-resolution PET [¹⁸F]fallypride study in cocaine dependent participants.
- Author
-
Fotros A, Casey KF, Larcher K, Verhaeghe JA, Cox SM, Gravel P, Reader AJ, Dagher A, Benkelfat C, and Leyton M
- Subjects
- Adult, Affect, Amygdala diagnostic imaging, Behavior, Addictive diagnostic imaging, Cocaine-Related Disorders diagnostic imaging, Cocaine-Related Disorders psychology, Corpus Striatum diagnostic imaging, Corpus Striatum metabolism, Cues, Female, Fluorine Radioisotopes, Hippocampus diagnostic imaging, Humans, Male, Neuroimaging, Radionuclide Imaging, Amygdala metabolism, Behavior, Addictive metabolism, Benzamides, Cocaine-Related Disorders metabolism, Dopamine metabolism, Hippocampus metabolism
- Abstract
Drug-related cues are potent triggers for relapse in people with cocaine dependence. Dopamine (DA) release within a limbic network of striatum, amygdala and hippocampus has been implicated in animal studies, but in humans it has only been possible to measure effects in the striatum. The objective here was to measure drug cue-induced DA release in the amygdala and hippocampus using high-resolution PET with [(18)F]fallypride. Twelve cocaine-dependent volunteers (mean age: 39.6 ± 8.0 years; years of cocaine use: 15.9 ± 7.4) underwent two [(18)F]fallypride high-resolution research tomography-PET scans, one with exposure to neutral cues and one with cocaine cues. [(18)F]Fallypride non-displaceable-binding potential (BPND) values were derived for five regions of interest (ROI; amygdala, hippocampus, ventral limbic striatum, associative striatum, and sensorimotor striatum). Subjective responses to the cues were measured with visual analog scales and grouped using principal component analysis. Drug cue exposure significantly decreased BPND values in all five ROI in subjects who had a high-, but not low-, craving response (limbic striatum: p=0.019, associative striatum: p=0.008, sensorimotor striatum: p=0.004, amygdala: p=0.040, and right hippocampus: p=0.025). Individual differences in the cue-induced craving response predicted the magnitude of [(18)F]fallypride responses within the striatum (ventral limbic: r=0.581, p=0.048; associative: r=0.589, p=0.044; sensorimotor: r=0.675, p=0.016). To our knowledge this study provides the first evidence of drug cue-induced DA release in the amygdala and hippocampus in humans. The preferential induction of DA release among high-craving responders suggests that these aspects of the limbic reward network might contribute to drug-seeking behavior.
- Published
- 2013
- Full Text
- View/download PDF
148. The neurobiology of depression--revisiting the serotonin hypothesis. II. Genetic, epigenetic and clinical studies.
- Author
-
Albert PR and Benkelfat C
- Subjects
- Animals, Antidepressive Agents therapeutic use, Depression drug therapy, Depression genetics, Epigenesis, Genetic, Genetic Predisposition to Disease, Humans, Neuroimaging, Raphe Nuclei drug effects, Raphe Nuclei metabolism, Raphe Nuclei physiopathology, Receptors, Serotonin drug effects, Receptors, Serotonin genetics, Receptors, Serotonin metabolism, Serotonin genetics, Serotonin Plasma Membrane Transport Proteins genetics, Serotonin Plasma Membrane Transport Proteins metabolism, Depression physiopathology, Serotonin metabolism
- Abstract
The serotonin system originates from a small number of neurons (a few hundred thousand of the 100 billion in man) located in the midbrain raphe nuclei, that project widely throughout the central nervous system to influence a large array of inter-related biological functions, not least of which are circuits involved in mood and emotion. The serotonin hypothesis of depression has postulated that a reduction in serotonin leads to increased predisposition to depression. Indeed, it has become evident from therapeutic strategies that affect serotonin activity, that alterations in serotonin may not only predispose to depression, but also to aggressive behaviour, impulsivity, obsessive-compulsive behaviour and suicide. Many potential mechanisms known to alter the genes that regulate the serotonin system, including developmental epigenetic modifications, are presented, as additional evidence implicating the serotonin system. This second issue of two special issues of Philosophical Transactions B presents a series of reviews, perspectives and new findings that argue that the serotonin hypothesis remains an important idea that continues to guide research into the aetiology and treatment of depression.
- Published
- 2013
- Full Text
- View/download PDF
149. The neurobiology of depression--revisiting the serotonin hypothesis. I. Cellular and molecular mechanisms.
- Author
-
Albert PR, Benkelfat C, and Descarries L
- Subjects
- Animals, Anxiety physiopathology, Depression genetics, Humans, Neurons drug effects, Neurons physiology, Serotonin genetics, Selective Serotonin Reuptake Inhibitors pharmacology, Social Behavior, Synaptic Transmission, Depression physiopathology, Serotonin physiology
- Abstract
The serotonin (5-HT) hypothesis of depression dates from the 1960s. It originally postulated that a deficit in brain serotonin, corrected by antidepressant drugs, was the origin of the illness. Nowadays, it is generally accepted that recurring mood disorders are brain diseases resulting from the combination, to various degrees, of genetic and other biological as well as environmental factors, evolving through the lifespan. All areas of neuroscience, from genes to behaviour, molecules to mind, and experimental to clinical, are actively engaged in attempts at elucidating the pathophysiology of depression and the mechanisms underlying the efficacy of antidepressant treatments. This first of two special issues of Philosophical Transactions B seeks to provide an overview of current developments in the field, with an emphasis on cellular and molecular mechanisms, and how their unravelling opens new perspectives for future research.
- Published
- 2012
- Full Text
- View/download PDF
150. The effects of age and estrogen on stress responsivity in older women.
- Author
-
Dumas JA, Albert KM, Naylor MR, Sites CK, Benkelfat C, and Newhouse PA
- Subjects
- Age Factors, Aged, Aged, 80 and over, Female, Humans, Middle Aged, Psychiatric Status Rating Scales, Psychological Tests, Affect drug effects, Estradiol pharmacology, Postmenopause drug effects, Stress, Psychological psychology
- Abstract
Objective: The current study examined whether age after menopause impacted the effect of estradiol (E2) on mood after a psychosocial stress manipulation., Background: Previous studies have shown that E2 improves mood in women around the menopause transition but does not improve mood for older postmenopausal women. We have previously shown that E2 treatment in nondepressed women resulted in increased negative mood after psychosocial stress., Design: Participants were 22 postmenopausal women placed on either oral placebo or 17β-estradiol (1 mg/day for 1 month, then 2 mg/day for 2 months)., Method: At the end of the 3-month treatment phase, the participants performed the Trier Social Stress Test followed by mood ratings. To examine the effects of age on the estrogen-stress interaction, we performed a median split on age and created four groups of participants: younger-placebo (mean age: 55.5 years), younger-E2 (mean age: 55.5 years), older-placebo (mean age: 73.0 years), and older-E2 (mean age: 76.8 years)., Results: : The results showed that both older and younger E2-treated participants exhibited a significant and similar increase in negative mood after psychosocial stress compared with placebo-treated women., Conclusions: These results suggest that E2 may play a significant role in modulating emotional reactivity to stressful events and that this effect persists in older women. Furthermore, responsivity to E2 effects on emotional processing appears to be intact even years after menopause in contrast with other cognitive and behavioral effects of E2, which may be limited to the early postmenopausal years.
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.